August 19, 2026
1 min read

Aurobindo unit, China API maker dinged in latest round of FDA warning letters

After receiving a checkered regulatory scorecard in 2024, Aurobindo’s sterile injectables and oncology unit is back in the FDA’s crosshairs.

Leave a Reply

Your email address will not be published.

Previous Story

How young athletes can fuel up for peak performance

Next Story

Men Over 50 Are at Increased Risk of Vitamin B12 Deficiency – And It Could Be Making Your Workouts Feel Harder

Previous Story

How young athletes can fuel up for peak performance

Next Story

Men Over 50 Are at Increased Risk of Vitamin B12 Deficiency – And It Could Be Making Your Workouts Feel Harder

Latest from Blog

Go toTop